Transaction #33641 · Form 4 · 0001193125-26-422957
Frazier Life Sciences Acquisition Corp. II · Purchase · Class A ordinary shares
Frazier Life Sciences Acquisition Corp. II · Transacted October 15, 2026 · Filed October 15, 2026
What does this filing report?
An SEC Form 4 filing for Frazier Life Sciences Acquisition Corp. II records a purchase involving Class A ordinary shares on October 15, 2026. The reported quantity was 300,000. The filing date is October 15, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0002153598
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 300,000
- Reported price
- 10
- Reference value
- 3,000,000
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 300,000
- Ownership description
- By Frazier Life Sciences Holdings II LLC
- SEC acceptance time
- Oct 15, 2026, 4:40 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Cha Albert ↗
Chief Executive Officer · Director · 10% owner
CIK 0001397906
- Frazier Life Sciences Public Fund, L.P. ↗
10% owner
CIK 0001863769
- FHMLSP, L.L.C. ↗
10% owner
CIK 0001879465
- FHMLSP, L.P. ↗
10% owner
CIK 0001879466
- Frazier Life Sciences Holdings II LLC ↗
10% owner
CIK 0002153600
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Securities held by Frazier Life Sciences Holdings II LLC ("Sponsor"). Albert Cha is the sole manager of Sponsor, and Frazier Life Sciences Public Fund, L.P. is its sole equity holder. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of its or his pecuniary interest therein, if any.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.